CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Seborrhoeic dermatitis - Management
When should I follow up?
- Routine follow up is not usually required.
- Advise seeking further medical advice if:
- Response to treatment is poor.
- Symptoms worsen despite treatment.
- Signs of infection (e.g. crusting, oozing, bleeding) develop.
Basis for recommendation
- CKS could find no guidelines or evidence on the follow up of seborrhoeic dermatitis in infants, and thus have made these pragmatic recommendations.
© NHS Institute for Innovation and Improvement